Wall St. Icon: “If you wait on this, it will already be too late”

If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.

Thomas Stankovich net worth and biography

Thomas Stankovich Biography and Net Worth

CFO of ReShape Lifesciences

Mr. Stankovich has over 25 years of executive leadership experience as the CFO for multiple public and private healthcare companies. Tom has spent the past nine years as the Global Senior Vice President and CFO of MP Biomedicals, a life sciences and molecular biology-diagnostics company. At MP Biomedicals he was responsible for financial planning and reporting, financial operations and strategy development along with the acquisition and integration of two international companies. Prior to MP Biomedicals, Tom served as CFO at Response Genetics where he successfully led the company through their initial public offering. Additionally, he served as CFO for Cobalis Corporation and for Ribapharm, where he also led the company through their initial public offering, which at the time became the second largest ever IPO in the biotechnology sector. Tom also held CFO positions at ICN International, which later changed names to Valeant Pharmaceuticals.

What is Thomas Stankovich's net worth?: The estimated net worth of Thomas Stankovich is at least $1,761.70 as of October 25th, 2023. Mr. Stankovich owns 395 shares of ReShape Lifesciences stock worth more than $1,762 as of December 24th. This net worth evaluation does not reflect any other investments that Mr. Stankovich may own. Additionally, Mr. Stankovich receives a salary of $307,120.00 as CFO at ReShape Lifesciences. Learn More about Thomas Stankovich's net worth.
How old is Thomas Stankovich?: Mr. Stankovich is currently 63 years old. There are 3 older executives and no younger executives at ReShape Lifesciences. The oldest executive at ReShape Lifesciences is Dr. Mark B. Knudson Ph.D., Co-Founder and Special Advisor to the CEO, who is 75 years old. Learn More on Thomas Stankovich's age.
What is Thomas Stankovich's salary?: As the CFO of ReShape Lifesciences Inc., Mr. Stankovich earns $307,120.00 per year. There are 3 executives that earn more than Mr. Stankovich. The highest earning executive at ReShape Lifesciences is Mr. Paul F. Hickey, CEO, President & Director, who commands a salary of $506,420.00 per year. Learn More on Thomas Stankovich's salary.
How do I contact Thomas Stankovich?: The corporate mailing address for Mr. Stankovich and other ReShape Lifesciences executives is 1001 Calle Amanecer, San Clemente CA, 92673. ReShape Lifesciences can also be reached via phone at (949) 429-6680 and via email at [email protected]. Learn More on Thomas Stankovich's contact information.
Has Thomas Stankovich been buying or selling shares of ReShape Lifesciences?: Thomas Stankovich has not been actively trading shares of ReShape Lifesciences over the course of the past ninety days. Most recently, Thomas Stankovich sold 2 shares of the business's stock in a transaction on Wednesday, October 25th. The shares were sold at an average price of $15.66, for a transaction totalling $31.32. Following the completion of the sale, the chief financial officer now directly owns 395 shares of the company's stock, valued at $6,185.70. Learn More on Thomas Stankovich's trading history.
Who are ReShape Lifesciences' active insiders?: ReShape Lifesciences' insider roster includes Barton Bandy (CEO), Dan Gladney (Director), and Thomas Stankovich (CFO). Learn More on ReShape Lifesciences' active insiders.

Thomas Stankovich Insider Trading History at ReShape Lifesciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/25/2023	Sell	2	$15.66	$31.32	395
10/11/2023	Sell	0	$53.94	$0.00	397
9/1/2023	Sell	2	$51.62	$103.24	398
8/24/2023	Sell	0	$82.36	$0.00	400
8/4/2023	Sell	1	$82.94	$82.94	401
7/6/2023	Sell	1	$85.26	$85.26	403
6/30/2023	Buy	305	$88.16	$26,888.80	405
5/31/2023	Sell	1	$139.78	$139.78	99
4/30/2023	Sell	1	$136.88	$136.88	101
3/31/2023	Sell	1	$150.80	$150.80	103
2/28/2023	Sell	1	$246.50	$246.50	105
2/2/2023	Sell	2	$770.82	$1,541.64	106
1/24/2023	Sell	2	$434.42	$868.84	109
11/4/2022	Sell	2	$783.00	$1,566.00	114
10/4/2022	Sell	2	$812.00	$1,624.00	116
9/6/2022	Sell	1	$1,131.00	$1,131.00	119
8/5/2022	Sell	1	$1,363.00	$1,363.00	121
7/1/2022	Sell	1	$1,595.00	$1,595.00	122
5/31/2022	Buy	6	$2,668.00	$16,008.00	126
4/1/2022	Sell	1	$3,277.00	$3,277.00	120
1/31/2022	Sell	1	$3,538.00	$3,538.00
1/4/2022	Sell	1	$5,162.00	$5,162.00
12/2/2021	Sell	1	$5,307.00	$5,307.00
11/18/2021	Buy	6	$5,858.00	$35,148.00
11/2/2021	Sell	1	$7,801.00	$7,801.00
10/1/2021	Sell	1	$8,004.00	$8,004.00
9/10/2021	Sell	16	$8,381.00	$134,096.00	108
8/30/2021	Buy	5	$9,947.00	$49,735.00	11
8/20/2021	Buy	5	$9,338.00	$46,690.00	6

Thomas Stankovich Buying and Selling Activity at ReShape Lifesciences

ReShape Lifesciences Company Overview

ReShape Lifesciences Inc. provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is also involved in developing ReShape Obalon Balloon System, consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and ReShape Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in Irvine, California.

Today's Range

Now: $4.46

$4.37

$4.46

50 Day Range

MA: $5.38

$4.26

$6.62

2 Week Range

Now: $4.46

$4.09

$29.00

Volume

3,522 shs

Average Volume

94,104 shs

Market Capitalization

$3.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

Wall St. Icon: “If you wait on this, it will already be too late”

From InvestorPlace | Ad

If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.

Go here now to see my urgent warning

Thomas Stankovich Biography and Net Worth

What is Thomas Stankovich's net worth?

How old is Thomas Stankovich?

What is Thomas Stankovich's salary?

How do I contact Thomas Stankovich?

Has Thomas Stankovich been buying or selling shares of ReShape Lifesciences?

Who are ReShape Lifesciences' active insiders?